|
Gland Pharma Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
27637.89 Cr.
|
P/BV
|
2.81
|
Book Value (Rs.)
|
596.28
|
|
52 Week High/Low (Rs.)
|
2131/1278
|
FV/ML
|
1/1
|
P/E(X)
|
39.57
|
|
Bookclosure
|
14/08/2025
|
EPS (Rs.)
|
42.40
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 1062.66 | 1132.54 | 1054.58 | 1618.55 | 1334.81 |
| | | | | | |
| Net CashFlow From Operating Activities | 914.73 | 996.80 | 363.97 | 790.77 | 604.93 |
| Net Cash Used In Investing Activities | 1704.74 | -1756.91 | 1208.19 | -1002.62 | -1524.00 |
| Net Cash Used From Financing Activities | -433.48 | -799.42 | 14.92 | 34.90 | 1238.46 |
| Foreign Exchange Gains / Losses | 13.13 | 7.72 | 3.00 | 3.31 | 3.58 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 2199.12 | -1551.81 | 1590.08 | -173.64 | 322.97 |
| Cash And Cash Equivalents Begin of Year | 357.09 | 1908.90 | 318.82 | 492.46 | 169.50 |
| Cash And Cash Equivalents End Of Year | 2556.21 | 357.09 | 1908.90 | 318.82 | 492.46 |
